Körber, a supplier of Manufacturing Execution Systems (MES) for the pharmaceutical, biotech and cell & gene therapy industries, and Inmation, a technology leader in global real-time information management, announce their partnership.

“With this agreement, we continue to pursue our best-of-breed partnership strategy and will offer our clients all components for Pharma 4.0 in a one-stop-shop,” says Jens Woehlbier, Chief Executive Officer (CEO) Software of KörberBusiness Area Pharma. “The solution enables a high level of integration in pharmaceutical production in a fast and cost-effective way. This provides customers with an integrated MES-historian solution from a single source, helping them move towards a data-driven future.”

“Our software solution enterprise:inmation has seen spectacular growth in the regulated life science industry recently,” explains Timo Klingenmeier, CEO of inmation Software. “One of the main drivers for our customers is the platform’s ability to integrate all production systems and create a fully contextualized ‘digital twin’ of pharmaceutical production data. The MES plays a key role in the system orchestration, and we are very proud to enter into a close partnership with Körber, the leader in the field. We will further drive the integration of both platforms and align closely to leverage both companies’ strength for the next-generation system architecture in life science,” adds Klingenmeier.

Körber offers its customers a best-practice solution by adding a state-of-the-art historian function to the Werum PAS-X MES Suite, which enables archiving of structured data. With their partnership, Körber and Inmation are striving to achieve a high degree of integration on the shop floor in brownfield pharmaceutical production.